- Home
- IOVA vs SENEA Comparison
IOVA vs SENEA Comparison
Compare IOVA & SENEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- SENEA
- Stock Information
- Founded
- IOVA 2007
- SENEA 1949
- Country
- IOVA United States
- SENEA United States
- Employees
- IOVA N/A
- SENEA N/A
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- SENEA Packaged Foods
- Sector
- IOVA Health Care
- SENEA Consumer Staples
- Exchange
- IOVA Nasdaq
- SENEA Nasdaq
- Market Cap
- IOVA 771.4M
- SENEA 699.2M
- IPO Year
- IOVA N/A
- SENEA N/A
- Fundamental
- Price
- IOVA $1.88
- SENEA $100.84
- Analyst Decision
- IOVA Buy
- SENEA
- Analyst Count
- IOVA 10
- SENEA 0
- Target Price
- IOVA $12.22
- SENEA N/A
- AVG Volume (30 Days)
- IOVA 10.4M
- SENEA 113.8K
- Earning Date
- IOVA 08-07-2025
- SENEA 08-07-2025
- Dividend Yield
- IOVA N/A
- SENEA N/A
- EPS Growth
- IOVA N/A
- SENEA N/A
- EPS
- IOVA N/A
- SENEA 5.90
- Revenue
- IOVA $212,679,000.00
- SENEA $1,578,887,000.00
- Revenue This Year
- IOVA $86.62
- SENEA N/A
- Revenue Next Year
- IOVA $69.95
- SENEA N/A
- P/E Ratio
- IOVA N/A
- SENEA $17.22
- Revenue Growth
- IOVA 11070.12
- SENEA 8.25
- 52 Week Low
- IOVA $1.64
- SENEA $56.36
- 52 Week High
- IOVA $12.51
- SENEA $106.83
- Technical
- Relative Strength Index (RSI)
- IOVA 47.47
- SENEA 57.36
- Support Level
- IOVA $1.68
- SENEA $98.61
- Resistance Level
- IOVA $2.02
- SENEA $106.83
- Average True Range (ATR)
- IOVA 0.11
- SENEA 3.46
- MACD
- IOVA 0.03
- SENEA 0.07
- Stochastic Oscillator
- IOVA 61.42
- SENEA 65.44
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About SENEA Seneca Foods Corp.
Seneca Foods Corp is a US-based company which acts as a provider of packaged fruits and vegetables. Its product offerings include canned, frozen, and bottled produce and snack chips. The company's segment includes Vegetable and Fruit/Snack. It generates maximum revenue from the Vegetable segment.